Targeted next-generation sequencing panel screening of 668 Chinese patients with non-obstructive azoospermia

Miao An1, Yidong Liu1, Ming Zhang1

  • 1Department of Urology and Andrology, Renji Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, 200001, People's Republic of China.

Summary

Next-generation sequencing (NGS) panels identify genetic causes of non-obstructive azoospermia (NOA). Certain gene mutations, like NR5A1, may predict micro-TESE success, while others suggest poor outcomes.

Related Concept Videos